RCM
AZN icon

RNC Capital Management’s AstraZeneca AZN Stock Holding History

RNC Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.17M Buy
32,535
+60
+0.2% +$11.3K 0.25% 53
2026
Q1 		$6.4M Sell
32,475
-543
-2% -$105K 0.28% 50
2025
Q4 		$6.07M Sell
33,018
-228
-0.7% -$40K 0.28% 50
2025
Q3 		$5.1M Buy
33,246
+3,107
+10% +$470K 0.23% 58
2025
Q2 		$4.21M Buy
30,139
+281
+0.9% +$39.4K 0.2% 61
2025
Q1 		$4.39M Buy
29,858
+1,020
+4% +$148K 0.22% 56
2024
Q4 		$3.78M Buy
28,838
+9,103
+46% +$1.27M 0.2% 59
2024
Q3 		$3.08M Hold
19,735
– – 0.17% 66
2024
Q2 		$3.08M Buy
19,735
+1,598
+9% +$240K 0.17% 66
2024
Q1 		$2.46M Sell
18,137
-339
-2% -$44.9K 0.14% 69
2023
Q4 		$2.49M Buy
18,476
+527
+3% +$68.5K 0.15% 64
2023
Q3 		$2.43M Sell
17,949
-347
-2% -$47.4K 0.15% 66
2023
Q2 		$2.62M Sell
18,296
-28,792
-61% -$4.24M 0.14% 79
2023
Q1 		$6.54M Sell
47,088
-2,225
-5% -$299K 0.37% 41
2022
Q4 		$6.69M Sell
49,313
-1,155
-2% -$145K 0.37% 43
2022
Q3 		$5.54M Sell
50,468
-202
-0.4% -$25.6K 0.35% 45
2022
Q2 		$6.7M Buy
50,670
+7,841
+18% +$1.03M 0.38% 41
2022
Q1 		$5.68M Buy
42,829
+16,401
+62% +$1.97M 0.29% 58
2021
Q4 		$3.08M Sell
26,428
-9,857
-27% -$1.16M 0.15% 81
2021
Q3 		$4.36M Buy
36,285
+22,225
+158% +$2.59M 0.23% 67
2021
Q2 		$1.68M Buy
+14,060
New +$1.54M 0.09% 93

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RNC Capital Management's AZN Position: Q2 2026 in Review

RNC Capital Management increased its AstraZeneca (AZN) stake by 0.18% in Q2 2026, buying an estimated $11.3K and bringing the position to 32,535 shares worth $6.17M. The position accounts for 0.25% of the portfolio, ranked #53.

RNC Capital Management first reported a position in AZN in Q2 2021 and has held it in 21 quarters since. The position peaked at $6.7M in Q2 2022. 1,501 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • RNC Capital Management held 32,535 shares of AstraZeneca worth $6.17M as of Q2 2026.
  • RNC Capital Management bought 60 AstraZeneca shares in Q2 2026, an estimated $11.3K.
  • AstraZeneca made up 0.25% of RNC Capital Management's portfolio in Q2 2026, its #53 holding.
  • RNC Capital Management first reported a position in AstraZeneca in Q2 2021 and has held it in 21 quarters since.
  • RNC Capital Management's AstraZeneca position peaked at $6.7M in Q2 2022.
  • 1,501 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on RNC Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.